High-Dose Ribavirin and Peginterferon to Treat Chronic Hepatitis C Genotype 1
Clinical trial NCT00735969 · COMPLETED
Trial details
- NCT number
- NCT00735969
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2013-06-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.